We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+1.45%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$77.7B
AUM Growth
+$28.1B
Cap. Flow
+$27.7B
Cap. Flow %
35.64%
Top 10 Hldgs %
8.03%
Holding
3,834
New
1,974
Increased
1,386
Reduced
336
Closed
47

Sector Composition

Rank Sector Weight
1 Technology 15.99%
2 Financials 14.9%
3 Industrials 12.22%
4 Consumer Discretionary 10.07%
5 Healthcare 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSE icon
3226
Inspired Entertainment
INSE
$175M
$10K ﹤0.01%
+1,433
New +$10.9K
KTCC icon
3227
Key Tronic
KTCC
$44.7M
$10K ﹤0.01%
+1,616
New +$8.53K
MRSN
3228
DELISTED
Mersana Therapeutics
MRSN
$10K ﹤0.01%
+258
New +$18.8K
NAII icon
3229
Natural Alternatives International
NAII
$14.9M
$10K ﹤0.01%
+1,138
New +$11.7K
PVL
3230
Permianville Royalty Trust
PVL
$57.1M
$10K ﹤0.01%
+4,003
New +$10.3K
RAIL icon
3231
FreightCar America
RAIL
$260M
$10K ﹤0.01%
+2,110
New +$10.6K
RELL icon
3232
Richardson Electronics
RELL
$304M
$10K ﹤0.01%
+1,692
New +$9.65K
RFIL icon
3233
RF Industries
RFIL
$139M
$10K ﹤0.01%
+1,415
New +$11K
SCYX icon
3234
SCYNEXIS
SCYX
$52M
$10K ﹤0.01%
+120
New +$11K
SUP
3235
DELISTED
Superior Industries International
SUP
$10K ﹤0.01%
+3,618
New +$10.5K
SYBX
3236
DELISTED
Synlogic
SYBX
$10K ﹤0.01%
+297
New +$21.5K
TPST icon
3237
Tempest Therapeutics
TPST
$14.6M
$10K ﹤0.01%
+7
New +$11.3K
TZOO icon
3238
Travelzoo
TZOO
$75.4M
$10K ﹤0.01%
+897
New +$11.1K
UG icon
3239
United-Guardian
UG
$33.5M
$10K ﹤0.01%
+521
New +$10.1K
VERI icon
3240
Veritone
VERI
$122M
$10K ﹤0.01%
+2,857
New +$16.3K
VHI icon
3241
Valhi
VHI
$450M
$10K ﹤0.01%
+458
New +$11.7K
ARAV
3242
DELISTED
Aravive, Inc. Common Stock
ARAV
$10K ﹤0.01%
+1,346
New +$8.39K
INFI
3243
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$10K ﹤0.01%
+9,635
New +$13.1K
JNCE
3244
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$10K ﹤0.01%
+2,910
New +$11.6K
AGRX
3245
DELISTED
Agile Therapeutics
AGRX
$10K ﹤0.01%
+4
New +$9.85K
FSTX
3246
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$10K ﹤0.01%
+703
New +$11.6K
OPNT
3247
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$10K ﹤0.01%
+683
New +$9.52K
OTIC
3248
DELISTED
Otonomy, Inc.
OTIC
$10K ﹤0.01%
+4,154
New +$9.89K
SOLY
3249
DELISTED
Soliton, Inc.
SOLY
$10K ﹤0.01%
+893
New +$11.5K
CBMB
3250
DELISTED
CBM Bancorp, Inc.
CBMB
$10K ﹤0.01%
+701
New +$9.68K

Similar funds

Victory Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Victory Capital Management held 3,834 positions worth $77.7B, up 57% from $49.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Victory Capital Management deployed $27.7B of net new capital in Q3 2019, opening 1,974 new positions and adding to 1,386 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,479,630 shares worth $316M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Reliance Steel & Aluminium, an estimated $98.7M trimmed.

  • Victory Capital Management's largest Q3 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,479,630 shares worth $316M.
  • Victory Capital Management added most to Microsoft in Q3 2019, an estimated $891M increase.
  • Victory Capital Management's biggest Q3 2019 reduction was Reliance Steel & Aluminium, cutting an estimated $98.7M.
  • Victory Capital Management fully exited Electronics for Imaging in Q3 2019, selling an estimated $61.5M.
  • Victory Capital Management's ten largest holdings make up 8% of its $77.7B portfolio in Q3 2019.
  • Victory Capital Management opened 1,974 new positions and closed 47 in Q3 2019.
  • Victory Capital Management's portfolio value rose 57% quarter-over-quarter to $77.7B.

Based on Victory Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.